Home > > > > > Report Detail

Global Bacterial Vaginosis Drugs Market Professional Survey Report 2019

Publisher Name :
Date: 08-Oct-2019
No. of pages: 102
Inquire Before Buying

Bacterial vaginosis is an imbalance of "good" and "bad" bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching. Treatments for bacterial vaginosis include the use of probiotics and medication. Common drug classes include lincosamide antibiotics and nitroimidazole antibiotics.

One driver in the market is unmet demand in BV treatment market. Unmet demand in the treatment of BV has created great opportunity for the market players. There is huge unmet need in the treatment of BV, especially the recurrent form of the disease. BV is the most common vaginal infection in the women of child bearing age group. Despite being highly prevalent in nature, little has been done in the field. When left untreated, it may lead to severe infections, especially in the case of pregnant women such as preterm births. rising awareness about women's health as one of the primary growth factors for the bacterial vaginosis drugs market. Owing to recent advancements in healthcare and the initiatives taken by the government and non-government organizations to increase the awareness about health of women, the demand for pharmaceuticals related to disorders in women will witness a significant increase in the coming years. Additionally, support from government is also a key driver.

The global Bacterial Vaginosis Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Bacterial Vaginosis Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bacterial Vaginosis Drugs market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Bacterial Vaginosis Drugs in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their Bacterial Vaginosis Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

- Bayer

- Pfizer

- Sanofi

- Starpharma Holdings

- ...

Segment by Regions

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Segment by Type

- Oral

- Topical

Segment by Application

- Pelvic Inflammatory Disease

- Preterm Delivery of Infants

- Urinary Tract Infection

- Sexually Transmitted Diseases (STD)

Global Bacterial Vaginosis Drugs Market Professional Survey Report 2019

Table of Contents
Executive Summary
1 Industry Overview of Bacterial Vaginosis Drugs
1.1 Definition of Bacterial Vaginosis Drugs
1.2 Bacterial Vaginosis Drugs Segment by Type
1.2.1 Global Bacterial Vaginosis Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oral
1.2.3 Topical
1.3 Bacterial Vaginosis Drugs Segment by Applications
1.3.1 Global Bacterial Vaginosis Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Pelvic Inflammatory Disease
1.3.3 Preterm Delivery of Infants
1.3.4 Urinary Tract Infection
1.3.5 Sexually Transmitted Diseases (STD)
1.4 Global Bacterial Vaginosis Drugs Overall Market
1.4.1 Global Bacterial Vaginosis Drugs Revenue (2014-2025)
1.4.2 Global Bacterial Vaginosis Drugs Production (2014-2025)
1.4.3 North America Bacterial Vaginosis Drugs Status and Prospect (2014-2025)
1.4.4 Europe Bacterial Vaginosis Drugs Status and Prospect (2014-2025)
1.4.5 China Bacterial Vaginosis Drugs Status and Prospect (2014-2025)
1.4.6 Japan Bacterial Vaginosis Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Bacterial Vaginosis Drugs Status and Prospect (2014-2025)
1.4.8 India Bacterial Vaginosis Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Bacterial Vaginosis Drugs
2.3 Manufacturing Process Analysis of Bacterial Vaginosis Drugs
2.4 Industry Chain Structure of Bacterial Vaginosis Drugs
3 Development and Manufacturing Plants Analysis of Bacterial Vaginosis Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Bacterial Vaginosis Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Bacterial Vaginosis Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Bacterial Vaginosis Drugs Production and Capacity Analysis
4.2 Bacterial Vaginosis Drugs Revenue Analysis
4.3 Bacterial Vaginosis Drugs Price Analysis
4.4 Market Concentration Degree
5 Bacterial Vaginosis Drugs Regional Market Analysis
5.1 Bacterial Vaginosis Drugs Production by Regions
5.1.1 Global Bacterial Vaginosis Drugs Production by Regions
5.1.2 Global Bacterial Vaginosis Drugs Revenue by Regions
5.2 Bacterial Vaginosis Drugs Consumption by Regions
5.3 North America Bacterial Vaginosis Drugs Market Analysis
5.3.1 North America Bacterial Vaginosis Drugs Production
5.3.2 North America Bacterial Vaginosis Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Bacterial Vaginosis Drugs Import and Export
5.4 Europe Bacterial Vaginosis Drugs Market Analysis
5.4.1 Europe Bacterial Vaginosis Drugs Production
5.4.2 Europe Bacterial Vaginosis Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Bacterial Vaginosis Drugs Import and Export
5.5 China Bacterial Vaginosis Drugs Market Analysis
5.5.1 China Bacterial Vaginosis Drugs Production
5.5.2 China Bacterial Vaginosis Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Bacterial Vaginosis Drugs Import and Export
5.6 Japan Bacterial Vaginosis Drugs Market Analysis
5.6.1 Japan Bacterial Vaginosis Drugs Production
5.6.2 Japan Bacterial Vaginosis Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Bacterial Vaginosis Drugs Import and Export
5.7 Southeast Asia Bacterial Vaginosis Drugs Market Analysis
5.7.1 Southeast Asia Bacterial Vaginosis Drugs Production
5.7.2 Southeast Asia Bacterial Vaginosis Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Bacterial Vaginosis Drugs Import and Export
5.8 India Bacterial Vaginosis Drugs Market Analysis
5.8.1 India Bacterial Vaginosis Drugs Production
5.8.2 India Bacterial Vaginosis Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Bacterial Vaginosis Drugs Import and Export
6 Bacterial Vaginosis Drugs Segment Market Analysis (by Type)
6.1 Global Bacterial Vaginosis Drugs Production by Type
6.2 Global Bacterial Vaginosis Drugs Revenue by Type
6.3 Bacterial Vaginosis Drugs Price by Type
7 Bacterial Vaginosis Drugs Segment Market Analysis (by Application)
7.1 Global Bacterial Vaginosis Drugs Consumption by Application
7.2 Global Bacterial Vaginosis Drugs Consumption Market Share by Application (2014-2019)
8 Bacterial Vaginosis Drugs Major Manufacturers Analysis
8.1 Bayer
8.1.1 Bayer Bacterial Vaginosis Drugs Production Sites and Area Served
8.1.2 Bayer Product Introduction, Application and Specification
8.1.3 Bayer Bacterial Vaginosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer Bacterial Vaginosis Drugs Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer Bacterial Vaginosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sanofi
8.3.1 Sanofi Bacterial Vaginosis Drugs Production Sites and Area Served
8.3.2 Sanofi Product Introduction, Application and Specification
8.3.3 Sanofi Bacterial Vaginosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Starpharma Holdings
8.4.1 Starpharma Holdings Bacterial Vaginosis Drugs Production Sites and Area Served
8.4.2 Starpharma Holdings Product Introduction, Application and Specification
8.4.3 Starpharma Holdings Bacterial Vaginosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
9 Development Trend of Analysis of Bacterial Vaginosis Drugs Market
9.1 Global Bacterial Vaginosis Drugs Market Trend Analysis
9.1.1 Global Bacterial Vaginosis Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Bacterial Vaginosis Drugs Regional Market Trend
9.2.1 North America Bacterial Vaginosis Drugs Forecast 2019-2025
9.2.2 Europe Bacterial Vaginosis Drugs Forecast 2019-2025
9.2.3 China Bacterial Vaginosis Drugs Forecast 2019-2025
9.2.4 Japan Bacterial Vaginosis Drugs Forecast 2019-2025
9.2.5 Southeast Asia Bacterial Vaginosis Drugs Forecast 2019-2025
9.2.6 India Bacterial Vaginosis Drugs Forecast 2019-2025
9.3 Bacterial Vaginosis Drugs Market Trend (Product Type)
9.4 Bacterial Vaginosis Drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Bacterial Vaginosis Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Picture of Bacterial Vaginosis Drugs
Table Global Bacterial Vaginosis Drugs Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Bacterial Vaginosis Drugs Production Market Share by Types in 2018
Figure Oral Product Picture
Figure Topical Product Picture
Table Global Bacterial Vaginosis Drugs Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Bacterial Vaginosis Drugs Consumption Market Share by Applications in 2018
Figure Pelvic Inflammatory Disease
Figure Preterm Delivery of Infants
Figure Urinary Tract Infection
Figure Sexually Transmitted Diseases (STD)
Figure Global Bacterial Vaginosis Drugs Revenue (Million USD) (2014-2025)
Figure Global Bacterial Vaginosis Drugs Production (K MT) (2014-2025)
Figure North America Bacterial Vaginosis Drugs Market Size (Million USD) (2014-2025)
Figure Europe Bacterial Vaginosis Drugs Market Size (Million USD) (2014-2025)
Figure China Bacterial Vaginosis Drugs Market Size (Million USD) (2014-2025)
Figure Japan Bacterial Vaginosis Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Bacterial Vaginosis Drugs Market Size (Million USD) (2014-2025)
Figure India Bacterial Vaginosis Drugs Market Size (Million USD) (2014-2025)
Table Bacterial Vaginosis Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Bacterial Vaginosis Drugs in 2018
Figure Manufacturing Process Analysis of Bacterial Vaginosis Drugs
Figure Industry Chain Structure of Bacterial Vaginosis Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Bacterial Vaginosis Drugs Manufacturing Plants Distribution
Table Bacterial Vaginosis Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Bacterial Vaginosis Drugs Capacity (K MT) of Major Manufacturers (2014-2019)
Table Bacterial Vaginosis Drugs Production (K MT) of Major Manufacturers (2014-2019)
Table Bacterial Vaginosis Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Bacterial Vaginosis Drugs Production Share by Manufacturers in 2018
Table Bacterial Vaginosis Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Bacterial Vaginosis Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Bacterial Vaginosis Drugs Revenue Share by Manufacturers in 2018
Table Bacterial Vaginosis Drugs Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Bacterial Vaginosis Drugs Production by Regions 2014-2019 (K MT)
Table Global Bacterial Vaginosis Drugs Production Market Share by Regions 2014-2019
Figure Global Bacterial Vaginosis Drugs Production Market Share by Regions in 2018
Table Global Bacterial Vaginosis Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Bacterial Vaginosis Drugs Revenue Market Share by Regions 2014-2019
Figure Global Bacterial Vaginosis Drugs Revenue Market Share by Regions in 2018
Table Global Bacterial Vaginosis Drugs Consumption by Regions 2014-2019 (K MT)
Table Global Bacterial Vaginosis Drugs Consumption Market Share by Regions 2014-2019
Figure North America Bacterial Vaginosis Drugs Production Growth Rate 2014-2019 (K MT)
Figure North America Bacterial Vaginosis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Bacterial Vaginosis Drugs Production, Consumption Import and Export (K MT)
Figure Europe Bacterial Vaginosis Drugs Production Growth Rate 2014-2019 (K MT)
Figure Europe Bacterial Vaginosis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Bacterial Vaginosis Drugs Production, Consumption Import and Export (K MT)
Figure China Bacterial Vaginosis Drugs Production Growth Rate 2014-2019 (K MT)
Figure China Bacterial Vaginosis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Bacterial Vaginosis Drugs Production, Consumption Import and Export (K MT)
Figure Japan Bacterial Vaginosis Drugs Production Growth Rate 2014-2019 (K MT)
Figure Japan Bacterial Vaginosis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Bacterial Vaginosis Drugs Production, Consumption Import and Export (K MT)
Figure Southeast Asia Bacterial Vaginosis Drugs Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Bacterial Vaginosis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Bacterial Vaginosis Drugs Production, Consumption Import and Export (K MT)
Figure India Bacterial Vaginosis Drugs Production Growth Rate 2014-2019 (K MT)
Figure India Bacterial Vaginosis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Bacterial Vaginosis Drugs Production, Consumption Import and Export (K MT)
Figure Global Consumption Bacterial Vaginosis Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Bacterial Vaginosis Drugs Market Share by Application (2014-2019)
Table Bayer Bacterial Vaginosis Drugs Production Sites and Area Served
Table Bayer Bacterial Vaginosis Drugs Product Introduction, Application and Specification
Table Bayer Bacterial Vaginosis Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Bayer Bacterial Vaginosis Drugs Production Growth Rate (2014-2019)
Table Bayer Bacterial Vaginosis Drugs Production Market Share (2014-2019)
Figure Bayer Bacterial Vaginosis Drugs Revenue Market Share (2014-2019)
Table Bayer Bacterial Vaginosis Drugs Main Business and Markets Served
Table Pfizer Bacterial Vaginosis Drugs Production Sites and Area Served
Table Pfizer Bacterial Vaginosis Drugs Product Introduction, Application and Specification
Table Pfizer Bacterial Vaginosis Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Bacterial Vaginosis Drugs Production Growth Rate (2014-2019)
Table Pfizer Bacterial Vaginosis Drugs Production Market Share (2014-2019)
Figure Pfizer Bacterial Vaginosis Drugs Revenue Market Share (2014-2019)
Table Pfizer Bacterial Vaginosis Drugs Main Business and Markets Served
Table Sanofi Bacterial Vaginosis Drugs Production Sites and Area Served
Table Sanofi Bacterial Vaginosis Drugs Product Introduction, Application and Specification
Table Sanofi Bacterial Vaginosis Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi Bacterial Vaginosis Drugs Production Growth Rate (2014-2019)
Table Sanofi Bacterial Vaginosis Drugs Production Market Share (2014-2019)
Figure Sanofi Bacterial Vaginosis Drugs Revenue Market Share (2014-2019)
Table Sanofi Bacterial Vaginosis Drugs Main Business and Markets Served
Table Starpharma Holdings Bacterial Vaginosis Drugs Production Sites and Area Served
Table Starpharma Holdings Bacterial Vaginosis Drugs Product Introduction, Application and Specification
Table Starpharma Holdings Bacterial Vaginosis Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Starpharma Holdings Bacterial Vaginosis Drugs Production Growth Rate (2014-2019)
Table Starpharma Holdings Bacterial Vaginosis Drugs Production Market Share (2014-2019)
Figure Starpharma Holdings Bacterial Vaginosis Drugs Revenue Market Share (2014-2019)
Table Starpharma Holdings Bacterial Vaginosis Drugs Main Business and Markets Served
Figure Global Bacterial Vaginosis Drugs Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Bacterial Vaginosis Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Bacterial Vaginosis Drugs Sales Price (USD/MT) Forecast 2019-2025
Figure North America Bacterial Vaginosis Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Bacterial Vaginosis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Bacterial Vaginosis Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Bacterial Vaginosis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Bacterial Vaginosis Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Bacterial Vaginosis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Bacterial Vaginosis Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Bacterial Vaginosis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Bacterial Vaginosis Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Bacterial Vaginosis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Bacterial Vaginosis Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Bacterial Vaginosis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Bacterial Vaginosis Drugs by Type (2019-2025)
Table Global Consumption (K MT) of Bacterial Vaginosis Drugs by Application (2019-2025)
Table Bacterial Vaginosis Drugs Distributors List
Table Bacterial Vaginosis Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs